Loading stock data...

Aarey Drugs & Pharmaceuticals Limited

BSE: AREYDRG

BSE
61.59 -2.16 (-3.39%)

Prev Close

63.75

Open Price

65.03

Volume

41,549

Today Low / High

61.27 / 65.7

52 WK Low / High

11.5 / 65.7

Range

59 - 65

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 61.59, reflecting a change of -2.16 (-3.3882%). The expected target range on the BSE is 59 - 65. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

Aarey Drugs & Pharmaceuticals Limited Graph

Aarey Drugs & Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Aarey Drugs & Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 61.59, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 61.59 62.21 55.99 - 68.43
62.82 50.26 - 75.39
63.44 44.41 - 82.47
Bearish Scenario 61.59 60.97 54.88 - 67.07
60.36 48.29 - 72.43
59.74 41.82 - 77.66

Overview of Aarey Drugs & Pharmaceuticals Limited

ISIN

INE198H01019

Industry

Vol.Avg

63,231

Market Cap

1,440,263,673

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

N/A

DCF

0

Financial Ratios Every Investor Needs

Stock Dividend of AREYDRG

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2018-12-13 December 13, 18 0.1 0.1 2018-12-14 2018-12-30

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 473.94 Cr 464.81 Cr 9.13 Cr 0.0193 0.00 Cr 0.00 Cr 0.31 Cr 4.02 Cr 1.43 12.06 Cr 0.0085
2024-03-31 395.10 Cr 381.90 Cr 13.20 Cr 0.0334 0.00 Cr 0.42 Cr 2.82 Cr 4.68 Cr 1.84 11.42 Cr 0.0119
2023-03-31 414.25 Cr 403.84 Cr 10.41 Cr 0.0251 0.00 Cr 0.88 Cr 6.69 Cr 3.77 Cr 1.49 8.27 Cr 0.0091
2022-03-31 491.61 Cr 472.06 Cr 19.54 Cr 0.0398 0.00 Cr 0.61 Cr 10.03 Cr 6.55 Cr 2.72 12.01 Cr 0.0133
2021-03-31 347.89 Cr 337.79 Cr 10.10 Cr 0.0290 0.00 Cr 0.32 Cr 8.23 Cr 6.51 Cr 2.79 9.15 Cr 0.0187

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 1.47 Cr 238.27 Cr 99.79 Cr 138.4805 Cr 34.86 Cr 33.38 Cr 45.48 Cr 16.22 Cr 0.00 Cr 0.00 Cr 8.76 Cr 96.8804 Cr
2024-03-31 1.59 Cr 303.29 Cr 170.52 Cr 132.7734 Cr 31.35 Cr 29.76 Cr 71.99 Cr 12.96 Cr 0.00 Cr 0.00 Cr 2.09 Cr 166.5469 Cr
2023-03-31 0.71 Cr 291.32 Cr 173.91 Cr 117.4138 Cr 37.72 Cr 37.01 Cr 28.82 Cr 13.94 Cr 5.28 Cr 0.00 Cr 0.41 Cr 168.1349 Cr
2022-03-31 0.19 Cr 245.17 Cr 131.53 Cr 113.6373 Cr 14.16 Cr 13.97 Cr 13.68 Cr 14.47 Cr 5.23 Cr -3.34 Cr 2.80 Cr 130.0762 Cr
2021-03-31 0.64 Cr 233.04 Cr 134.18 Cr 98.8605 Cr 18.02 Cr 17.38 Cr 18.46 Cr 14.26 Cr 4.25 Cr 0.00 Cr 0.40 Cr 132.6120 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 0.8948 Cr -5.9394 Cr 4.9237 Cr -4.3096 Cr 0.0000 Cr 1.4733 Cr -5.2044 Cr 4.0239 Cr 3.2337 Cr 0.0000 Cr -10.8045 Cr
2024-03-31 -2.9938 Cr -1.7023 Cr 5.5848 Cr -3.7161 Cr 0.8886 Cr 1.5944 Cr -0.7223 Cr 4.6837 Cr -1.1362 Cr 0.0000 Cr -5.8566 Cr
2023-03-31 -1.2811 Cr 0.4410 Cr 1.3540 Cr -2.3251 Cr 0.5139 Cr 0.7058 Cr -1.0440 Cr 6.0151 Cr 4.2211 Cr 0.0000 Cr -15.1352 Cr
2022-03-31 -4.4930 Cr -2.1967 Cr 6.2319 Cr -6.6943 Cr -0.4578 Cr 0.1919 Cr -2.2013 Cr 10.0271 Cr 0.0000 Cr 0.0000 Cr 4.7767 Cr
2021-03-31 5.4770 Cr -2.8793 Cr -2.4507 Cr 2.5977 Cr 0.1470 Cr 0.6497 Cr -2.8793 Cr 8.3014 Cr -0.0191 Cr 0.0000 Cr -1.4646 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-03-31 108.10 Cr 108.02 Cr 0.08 Cr 0.0007 -3.43 Cr 0.47 Cr 0.02 2.69 Cr 0.0043
2024-12-31 133.79 Cr 130.39 Cr 3.40 Cr 0.0254 1.62 Cr 0.72 Cr 0.26 2.88 Cr 0.0054
2024-09-30 105.14 Cr 98.90 Cr 6.24 Cr 0.0594 3.23 Cr 1.60 Cr 0.57 3.74 Cr 0.0152
2024-06-30 126.91 Cr 123.59 Cr 3.32 Cr 0.0261 2.58 Cr 1.24 Cr 0.44 2.75 Cr 0.0098
2024-03-31 210.35 Cr 206.75 Cr 3.60 Cr 0.0171 -1.84 Cr 2.15 Cr 0.77 3.70 Cr 0.0102

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 1.47 Cr 0.00 Cr 1.47 Cr 159.55 Cr 45.48 Cr 213.28 Cr 16.22 Cr 238.27 Cr 99.79 Cr
2024-12-31 0.00 Cr 0.00 Cr 1.49 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -135.59 Cr
2024-09-30 1.49 Cr 0.00 Cr 1.49 Cr 0.00 Cr 29.84 Cr 251.35 Cr 12.99 Cr 274.53 Cr 138.94 Cr
2024-06-30 0.00 Cr 0.00 Cr 2.89 Cr 0.00 Cr 0.00 Cr 2.89 Cr 0.00 Cr 0.00 Cr -132.77 Cr
2024-03-31 1.59 Cr 1.30 Cr 1.59 Cr 200.85 Cr 34.68 Cr 282.60 Cr 14.66 Cr 304.99 Cr 172.22 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-12-31 0.72 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 1.60 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 1.24 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 2.15 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 1.02 Cr 0.94 Cr 0.00 Cr 0.00 Cr 0.94 Cr 2.11 Cr 1.17 Cr 0.00 Cr 0.94 Cr

Splits History

Date Label Split Ratio
2017-10-12 October 12, 17 10:1
2012-06-25 June 25, 12 6:5

Industry not found. Cannot fetch stock data.